Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models

Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models

Cognitive impairments in Huntington's disease (HD) are attributed to a dysfunction of the cortico-striatal pathway and significantly affect the quality of life of the patients, but this has not been a therapeutic focus in HD to date. We postulated that adenosine A2A receptors (A2AR), located at...

Full description

Bibliographic Details
Main Authors:	Wei Li, Henrique B. Silva, Joana Real, Yu-Mei Wang, Daniel Rial, Ping Li, Marie-Pierce Payen, Yuanguo Zhou, Christa E. Muller, Angelo R. Tomé, Rodrigo A. Cunha, Jiang-Fan Chen
Format:	Article
Language:	English
Published:	Elsevier 2015-07-01
Series:	Neurobiology of Disease
Subjects:	Adenosine A2A receptor Huntington's disease Cognition Working memory Long-term depression R6/2 mice
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996115001278

Similar Items

Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease
by: Antonella Ferrante, et al.
Published: (2014-11-01)

Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington’s disease mice
by: M.R. Domenici, et al.
Published: (2007-11-01)

Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow
by: M. Gianfriddo, et al.
Published: (2004-10-01)

Remodeling of striatal NMDA receptors by chronic A2A receptor blockade in Huntington's disease mice
by: Alberto Martire, et al.
Published: (2010-01-01)

Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease
by: Xavier Guitart, et al.
Published: (2016-12-01)

Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
by: Melissa Talita Wiprich, et al.
Published: (2021-07-01)

A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease
by: Stéphane Mievis, et al.
Published: (2011-02-01)

Extracellular adenosine-mediated modulation of regulatory T cells
by: Akio eOhta, et al.
Published: (2014-07-01)

Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages
by: K. Varani, et al.
Published: (2007-07-01)

Association between caffeine intake and age at onset in Huntington's disease
by: Clémence Simonin, et al.
Published: (2013-10-01)

How Are Adenosine and Adenosine A<sub>2A</sub> Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
by: Akihisa Mori, et al.
Published: (2021-08-01)

The Role of Adenosine Receptors in Psychostimulant Addiction
by: Inmaculada Ballesteros-Yáñez, et al.
Published: (2018-01-01)

A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
by: Claire-Marie Dhaenens, et al.
Published: (2009-09-01)

Exosomes as a potential messenger unit during heterochronic parabiosis for amelioration of Huntington's disease
by: Mijung Lee, et al.
Published: (2021-07-01)

Inhibition of astrocytic adenosine receptor A2A attenuates microglial activation in a mouse model of Sandhoff disease
by: Yasuhiro Ogawa, et al.
Published: (2018-10-01)

A metabolic immune checkpoint: adenosine in tumor microenvironment
by: Akio eOhta
Published: (2016-03-01)

Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells
by: Claudia Sorrentino, et al.
Published: (2019-02-01)

Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease
by: António C. Silva, et al.
Published: (2018-09-01)

Corrigendum: Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells
by: Claudia Sorrentino, et al.
Published: (2019-05-01)

Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation
by: Dasiel O. Borroto-Escuela, et al.
Published: (2018-02-01)

Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice
by: Jack C. Reidling, et al.
Published: (2018-01-01)

Role of adenosine in oligodendrocyte precursor maturation
by: Elisabetta eCoppi, et al.
Published: (2015-04-01)

Adenosine A<sub>2A</sub> Receptors Are Upregulated in Peripheral Blood Mononuclear Cells from Atrial Fibrillation Patients
by: Héctor Godoy-Marín, et al.
Published: (2021-03-01)

Quantitative prediction of selectivity between the A1 and A2A adenosine receptors
by: Lindsey Burggraaff, et al.
Published: (2020-05-01)

Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A<sub>2B</sub> Receptor Binding Affinity
by: Marcel Lindemann, et al.
Published: (2021-05-01)

Mast cell adenosine receptors function: a focus on the A3 adenosine receptor and inflammation
by: Noam eRudich, et al.
Published: (2012-06-01)

Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition
by: M. Maltese, et al.
Published: (2017-12-01)

Stimulatory effects of adenosine on prolactin secretion in the pituitary gland of the rat
by: D.L.W. Picanço-Diniz, et al.
Published: (2002-07-01)

Effect of Simultaneous Administration of Felodipine with CCPA (A1 adenosine receptor agonist) or SCH58261 (Adenosine A2A receptor antagonist) on Morphine Withdrawal Syndrome
by: gisoo Mohaddes, et al.
Published: (2014-11-01)

Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis
by: Elizabeth A. Vecchio, et al.
Published: (2017-05-01)

Phenotyping of Mice with Heart Specific Overexpression of A2A-Adenosine Receptors: Evidence for Cardioprotective Effects of A2A-Adenosine Receptors
by: Peter Boknik, et al.
Published: (2018-01-01)

Cyp2j5-Gene Deletion Affects on Acetylcholine and Adenosine-Induced Relaxation in Mice: Role of Angiotensin-II and CYP-Epoxygenase Inhibitor
by: Stephanie Agba, et al.
Published: (2020-02-01)

P2X7 Receptor Agonist 2′(3′)-O-(4-Benzoylbenzoyl)ATP Differently Modulates Cell Viability and Corticostriatal Synaptic Transmission in Experimental Models of Huntington’s Disease
by: Alberto Martire, et al.
Published: (2021-02-01)

Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease
by: Ido Rippin, et al.
Published: (2021-07-01)

Pharmacological Blockade of Adenosine A2A but Not A1 Receptors Enhances Goal-Directed Valuation in Satiety-Based Instrumental Behavior
by: Yan Li, et al.
Published: (2018-04-01)

Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease
by: Emilie Faivre, et al.
Published: (2018-07-01)

Crosstalk Between ATP-P2X7 and Adenosine A2A Receptors Controlling Neuroinflammation in Rats Subject to Repeated Restraint Stress
by: Liliana Dias, et al.
Published: (2021-03-01)

Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins
by: Estefanía Moreno, et al.
Published: (2018-02-01)

Unawareness of deficits in Huntington's disease
by: McGlynn, Susan Mary, 1960-
Published: (1989)

Targeting adenosine for cancer immunotherapy
by: Robert D. Leone, et al.
Published: (2018-06-01)